Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 24, 2022
Patent Application Number
16847229
Date Filed
April 13, 2020
Patent Citations
Patent Primary Examiner
The present invention provides antagonizing antibodies that bind to programmed cell death protein 1 (PD-1) and methods of using same. The anti-PD-1 antibodies can be used therapeutically alone or in combination with other therapeutics to treat cancer and other diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
